Leo Lewis is the Asia Business Editor at the Financial Times, based in Tokyo. He covers a wide range of topics including finance, business, and economics in the Asian region. With a focus on Japan, he provides in-depth analysis and insights into the country's corporate landscape and economic developments.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Leo Lewis' articles primarily focus on finance and the economy of Japan, with an emphasis on investment analysis. He delves into topics such as Japanese stock market, companies, technology, culture and the broader economic landscape.
Based on this coverage profile, Leo is likely to be receptive to pitches that offer in-depth insights into the Japanese financial markets or showcase expert perspectives related to investments in Japan. If you have expertise in analyzing the Japanese economy or specific sectors within it such as technology or traditional industries like scallop farming mentioned in one of his articles, your input might be valuable for him.
It's important to note that Leo's geographic focus is clearly centered around Japan; therefore any pitches should tie back directly to developments within this region for relevance.
This information evolves through artificial intelligence and human feedback. Improve this profile .
One hundred days before the opening of the 2024 Paris Olympics, Toyota fired up its promotional campaign for the games by unleashing an inspirational "send off" video on social media.
I'm a human being God damn it! My life has value! . . . I'm as mad as hell, and I'm not going to take this any more!
By: Thomas Hale, Wang Xueqiao, Leo Lewis
China's urban pet population will surpass the number of children under the age of four this year, according to Goldman Sachs, creating a
By: Leo Lewis, Arjun Neil Alim, George Steer
Banks and tech stocks fare worst as weak US economic data could push Fed into making rapid interest rate cuts
On Tuesday, Jefferies reiterated its Buy rating on Globus Medical (NYSE:) with a steady price target of $85.00. The firm's stance remains positive despite the stock experiencing a significant drop in early trading. This decline followed the posting of a warning letter from the U.S. Food and Drug Administration (FDA) on July 15.
By: Leo Lewis, David Keohane
The takeover offer has the potential to kick-start a wave of M&A activity in a country that has tended to avoid it Author of the article:
By: Leo Lewis, Thomas Hale
Editor's Note: This story comes from CableTV.com Halloween is almost here — whatcha gonna watch while you gobble up all that candy? What's that?
The Nippon Steel experience has broader ramifications for dealmaking, says Leo Lewis for the Financial Times.
By: Leo Lewis, Robin Harding
Who hasn't dreamed of being born into a wealthy family? Or fantasized about what it might be like to have an unknown great-uncle or aunt who passes away and leaves behind a fortune?
Since the first bullet train left Tokyo Station six decades ago, it has become an icon of speed, style and national identity. Leo Lewis
(833) 317-6278 
